Real REMAX (REAX) Q3 2026 Earnings Call Transcript

Real RE/MAX reported Q3 revenue of $727.9 million, up 28% year over year, and adjusted EBITDA of $33.8 million, up 66%; results included about five weeks of RE/MAX contribution, while a $67.2 million GAAP net loss included $78.7 million of nonrecurring acquisition-related expenses. Management has actioned $40 million in annualized gross savings, including $28 million in adjusted EBITDA synergies, and guided to 2027 revenue of $2.6 billion–$2.8 billion and adjusted EBITDA of $175 million–$190 million. That outlook assumes U.S. existing home sales fall 5%–10% and average home prices decline 3%–4%, reflecting continued housing-market weakness.

Analysis

REAX is an integration-and-execution story with a housing downturn acting as the stress test. The main earnings asymmetry is that cost actions are more controllable than transaction volumes, but announced savings are not equivalent to realized EBITDA: capitalized software and stock compensation are excluded from the EBITDA bridge, and the remaining savings phase in over 2027. A further housing deterioration could therefore erase part of the expected operating leverage before synergies fully arrive. Conversely, if transactions merely stabilize rather than recover, cost removal plus Real’s production gains may support EBITDA better than the headline agent-count trend implies; agent counts are a poor proxy unless production per agent and retention of high producers hold up.

The key valuation risk is cash conversion, not adjusted EBITDA alone. Material stock-based compensation, interest expense and planned debt repayment compete with buybacks and technology investment; monitor diluted share growth, cash interest coverage and net leverage alongside adjusted EBITDA. REAX’s technology opportunity is also two-sided: subscription uptake is an early adoption signal, not evidence yet of durable retention, productivity gains or meaningful ancillary attach. RE/MAX rollout could improve franchise-owner economics, but implementation and cultural integration create a multi-quarter execution risk. Open Real Estate may improve listing-data access while also weakening control over a historically differentiated distribution channel; economics remain unproven.

Near term, expect guidance assumptions and mortgage-rate moves to dominate. Over 1–3 months, test whether synergies phase in and whether REAX retains productive agents; over 6–18 months, the thesis depends on franchise stabilization, software adoption and debt reduction. The market may underweight cost flexibility but overvalue AI and gross savings before demonstrated cash results. Valuation and current price are not supplied, so the earnings call alone does not establish an attractive entry.

Key Decisions for Investors

• No outright REAX position on this evidence alone. Reassess after the next report using realized EBITDA contribution versus the stated synergy ramp, free cash flow after interest and capex, and net leverage; require valuation support before underwriting the upside.
• Set an alert for REAX if housing volumes weaken further: watch transaction sides and production per agent, not roster size alone. A material deterioration in high-producing agent retention or a guidance cut would falsify the operating-resilience thesis.
• Treat LEO Pro and the RE/MAX technology rollout as a catalyst to verify, not a present earnings driver. Track paid-user retention, usage, measurable agent productivity, and whether mortgage/title attach improves from current low levels before capitalizing meaningful recurring revenue.
• Do not use RMAX as a proxy for the reported results: the supplied identity maps RMAX to RE/MAX Holdings, Inc., while the article’s combined-company claims concern REAX.